AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E400760-T1: [Translated] SYSTEM AND METHOD FOR USING BENT TUBES IN A HIGH PURITY LIQUID TREATMENT SYSTEM

A novel method (500) for bending tubes (102; 410; 412; 414) suitable for use in high-purity fluid handling systems (400) includes selecting (502) a tube (102; 410; 412; 414) made from a material having a grain-size number of at least 5, and forming (504) a bend (104) in the tube with a bend radius (108) of greater than 1.5 times the diameter of the tube (102; 410; 412; 414). Tubes (102; 410; 412; 414) bent according to the present invention are incorporated into high-purity systems (400) as supply lines, product lines, and vacuum forelines, without the need for post-bend heat treatment or polishing (Fig. 5).
The Zebrafish Model Organism Database (ZFIN)

<p>ZFIN serves as the zebrafish model organism database. It aims to: a) be the community database resource for the laboratory use of zebrafish, b) develop and support integrated zebrafish genetic, genomic and developmental information, c) maintain the definitive reference data sets of zebrafish research information, d) to link this information extensively to corresponding data in other model organism and human databases, e) facilitate the use of zebrafish as a model for human biology, and f) serve the needs of the research community.</p>
Compound 525855: N,N-Dimethyl-2-phenyl-N'-(4-ethoxyphenyl)-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-ethoxyphenyl)-N,N-dimethyl-2-phenylethanimidamide. Molecular Formula: C18H22N2O. Molecular Weight: 282.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399793-T1: [Translated] COMPOUNDS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER

Compounds and methods for the treatment and diagnosis of lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.
Patent AT-E400201-T1: [Translated] SHOE

The invention relates to a shoe ( 1 ), especially a sports shoe, comprising a sole ( 2 ) and a shoe upper part ( 3 ) linked therewith, the sole ( 2 ) having a receptacle ( 4 ) in which a damping element ( 5 ) is detachably arranged. The aim of the invention is to improve the cushioning and damping behavior of the shoe. According to the Invention, the receptacle ( 4 ) substantially or completely extends through the sole ( 2 ) at an angle to the longitudinal axis (L) of the shoe ( 1 ) and the detachably mounted damping element ( 5 ) is constituted of a plate-type base ( 6 ) that comprises a plurality of recesses ( 7 ) in which damping parts ( 8 ) can be disposed. The recesses ( 7 ) in the damping element ( 5 ) extend across the entire height (H) of the damping element ( 5 ) in the vertical direction (V).
Genetic epidemiology: Systemic sclerosis

Systemic sclerosis (SSc) is a multisystem connective tissue disease characterised phenotypically by fibrosis and ischaemic atrophy. Its aetiology is most likely multifactorial. A genetic predisposition to the condition is suggested by reports of familial SSc (a positive family history is the strongest risk factor yet identified), by animal models, and by disease-association studies, in which researchers have examined a wide variety of genes including those involved in fibrosis, in vascular function and structure, and in autoimmunity – the relative rarity of SSc has precluded linkage studies, except in the Choctaw Indians. Recent advances in genetic methodologies should further our understanding of this complex disease process.
Concordance between genetic relatedness and phenotypic similarities of

Background
          Despite the medical importance of trichomoniasis, little is known about the genetic relatedness of Trichomonas vaginalis strains with similar biological characteristics. Furthermore, the distribution of endobionts such as mycoplasmas or Trichomonas vaginalis virus (TVV) in the T. vaginalis metapopulation is poorly characterised.
        
        
          Results
          We assayed the relationship between 20 strains of T. vaginalis from 8 countries using the Random Amplified Polymorphic DNA (RAPD) analysis with 27 random primers. The genealogical tree was constructed and its bootstrap values were computed using the program FreeTree. Using the permutation tail probability tests we found that the topology of the tree reflected both the pattern of resistance to metronidazole (the major anti-trichomonal drug) (p < 0.01) and the pattern of infection of strains by mycoplasmas (p < 0.05). However, the tree did not reflect pattern of virulence, geographic origin or infection by TVV. Despite low bootstrap support for many branches, the significant clustering of strains with similar drug susceptibility suggests that the tree approaches the true genealogy of strains. The clustering of mycoplasma positive strains may be an experimental artifact, caused by shared RAPD characters which are dependent on the presence of mycoplasma DNA.
        
        
          Conclusions
          Our results confirmed both the suitability of the RAPD technique for genealogical studies in T. vaginalis and previous conclusions on the relatedness of metronidazol resistant strains. However, our studies indicate that testing analysed strains for the presence of endobionts and assessment of the robustness of tree topologies by bootstrap analysis seem to be obligatory steps in such analyses.
Compound 529329: Oxetane, 3-methyl-3-(4-methylphenyloxy)methyl

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-3-[(4-methylphenoxy)methyl]oxetane. Molecular Formula: C12H16O2. Molecular Weight: 192.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529753: 17alpha-Ethinylestrdiol, di-trimethylsilyl

Chemical compound data from PubChem database. IUPAC Name: (17-ethynyl-13-methyl-3-trimethylsilyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)oxy-trimethylsilane. Molecular Formula: C26H40O2Si2. Molecular Weight: 440.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
4.17b Facilities employing specific practices as part of their standard operating procedures, by facility operation and primary focus of facility: 2010. Percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities employing specific practices as part of their standard operating procedures, by facility operation and primary focus of facility in 2010. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 527057: 2-Cyclohexen-1-one, 4-(3-hydroxybutylidene)-3,5,5-trimethyl-

Chemical compound data from PubChem database. IUPAC Name: 4-(3-hydroxybutylidene)-3,5,5-trimethylcyclohex-2-en-1-one. Molecular Formula: C13H20O2. Molecular Weight: 208.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014-2016 Substate Estimates of Substance Use and Mental Illness

Substate estimates for 15 measures of substance use and mental illness based on the combined 2014, 2015, and 2016 National Surveys on Drug Use and Health (NSDUHs) are provided. NSDUH is an ongoing survey of the civilian, noninstitutionalized population of the United States aged 12 years or older. Estimates presented here are based on a small area estimation (SAE) methodology in which substate-level NSDUH data are combined with county and census block group/tract-level data from the state.
National Immunization Survey Fall Respiratory Virus Module (NIS-FRVM): RespVaxView| Data | Centers for Disease Control and Prevention (cdc.gov)

• National Immunization Survey Fall Respiratory Virus Module (NIS-FRVM): CDC is providing information on the updated 2025-26 COVID-19 vaccine, the 2025-26 seasonal flu vaccine, and the RSV vaccine uptake and confidence. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics.

• The data start in October 2025.

• The archived data can be found here:
- 2024-25 season: https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/si7g-c2bs/about_data 
- 2023-24 season: https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/uc4z-hbsd/about_data
- Before October 2023:
https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/udsf-9v7b/about_data
Laryngeal dysfunction in Amyotrophic Lateral Sclerosis: a review and case report

Background
          Laryngeal dysfunction can be a salient feature in the clinical symptomatology of speakers diagnosed with Amyotrophic Lateral Sclerosis (ALS). In addition to dysphonia, swallowing function is also disrupted. This paper reviews what is known about laryngeal dysfunction resulting from ALS.
        
        
          Results
          Presented is a case report of a female, diagnosed with ALS, whose initial symptoms were caused by laryngeal bulbar involvement that was characterized by dysphonia and dysphagia.
        
        
          Conclusions
          In bulbar forms of ALS, voice and/or swallowing difficulties are often the initial signs of disease. Careful examination of the muscles innervated by bulbar nerves, and tracking the rate of progressive deficit in the affected muscles, will help to solidify an accurate diagnosis. With therapy, the ability to swallow safely may still be maintained even when voice and articulation abilities are such that oral communication is inefficient.
Patent AT-E400598-T1: [Translated] POLYURETHANES FREE OF ORGANIC METAL COMPOUNDS WITH A SMALL EXTRACTABLE PROPORTION

Breathable thermoplastic polyurethanes are prepared from the reaction of a polyol component, a polyisocyanate component, and a chain extender in the presence of a metal-free catalyst. The metal-free catalyst comprises a polyalcohol amine, a tertiary amine catalyst, or a combination thereof. The polyurethanes of the present invention are suitable for film applications as they form breathable films which are permeable to water vapor but not air or water. The polyurethane compositions are substantially metal-free, have low extractables, and excellent melt strength.
Patent AT-E401086-T1: [Translated] COMPOSITION CONTAINING TREHALOSE AND ZINC AND THE USE THEREOF FOR INHIBITING SKIN IRRITATION

Compositions for reducing an adverse skin reaction caused by a skin-irritating agent or skin sensitizing agent by treatment with a disaccharide and a metal ion, as well as methods for reducing an adverse skin reaction caused by a skin-irritating or skin-sensitizing agent, and methods for treating an inflammatory response to at least one inflammatory agent, by application of a disaccharide and/or metal ion composition.
Adoption and Foster Care Analysis and Reporting System (AFCARS); Proposed Rule

Adoption and Foster Care Analysis and Reporting System (AFCARS); Proposed Rule
  
  

 (PDF) - This notice of proposed rulemaking describes numerous improvements to Adoption and Foster Care Analysis and Reporting System (AFCARS) data, including changes to the reporting populations, data structure, elements, compliance determination, and penalty provisions.

Metadata-only record linking to the original dataset. Open original dataset below.
Guaifenesin and pseudoephedrine hcl

Guaifenesin and Pseudoephedrine HCl is an over-the-counter extended-release tablet that helps relieve chest congestion and nasal congestion. It combines guaifenesin, an expectorant that loosens mucus, with pseudoephedrine HCl, a decongestant that shrinks swollen blood vessels in the nasal passages. Available in strengths like 600mg guaifenesin and 60mg pseudoephedrine HCl per tablet, it's manufactured by Dr. Reddy's Laboratories Limited and marketed by Walgreens. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E400232-T1: [Translated] ELECTROSURGICAL SUCTION-ABLATION DEVICE

An aspirating ablator of simple construction and low cost is disclosed. The aspirating ablator is provided with a mandrel connected to a tubular member which houses a suction assembly. An electrode having a rectangular ablation surface formed of multiple parallel ribs or protuberances is assembled onto the mandrel so that the ablation surface is parallel with the longitudinal axis of the mandrel. A ceramic insulator with an opening is assembled to the electrode-mandrel assembly in order to separate/isolate the protuberances from each other. The insulator is further provided with a cylindrical passage in communication and aligned with a radial passage of the mandrel. <IMAGE>
Compound 2: 2-(Acetyloxy)-3-carboxy-N,N,N-trimethylpropan-1-aminium

Chemical compound data from PubChem database. IUPAC Name: (2-acetyloxy-3-carboxypropyl)-trimethylazanium. Molecular Formula: C9H18NO4+. Molecular Weight: 204.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 CMHS Uniform Reporting System (URS) Table for Nebraska

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Nebraska. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Quality Assurance Reporting Requirements (QARR) Health Disparities 2018

This dataset includes Medicaid Managed Care, Commercial HMO, and Commercial PPO performance data from the Quality Assurance Reporting Requirements (QARR) by member demographic characteristics. QARR is largely based on measures of quality developed and published by the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®). Plans are required to submit quality performance data each year. Demographic information analyzed in this report includes members’ sex, age, race/ethnicity, Medicaid aid category, cash assistance status, behavioral health conditions including serious mental illness (SMI) and substance use disorder (SUD), payer status, and region of residence. Measuring the quality of care, and the ability to measure disparities in care is an important first step to a better understanding of the underlying factors that drive differences in care among certain populations within Medicaid Managed Care, Commercial HMO, and Commercial PPO.
<p>These data are published annually for Medicaid Managed Care in the Health Care Disparities in New York State Report and on the NYSDOH website: https://www.health.ny.gov/health_care/managed_care/reports/ </p>
Compound 529127: Silane, [1,5-pentanediylbis(oxy)]bis[(1,1-dimethylethyl)dimethyl-

Chemical compound data from PubChem database. IUPAC Name: tert-butyl-[5-[tert-butyl(dimethyl)silyl]oxypentoxy]-dimethylsilane. Molecular Formula: C17H40O2Si2. Molecular Weight: 332.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528586: tert-Butyl(dimethyl)silyl nonanoate

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] nonanoate. Molecular Formula: C15H32O2Si. Molecular Weight: 272.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Family Structure and Functioning in Neglectful Families, 1991-1993

The investigator also looked at the effects of race, chronicity of neglect, and personality factors. Study participants were recruited from the Georgia Department of Family and Children's Services by caseworkers who found them to meet NIS-2 definitions of neglect, were verified as neglectful upon investigation, and had at least one child between the ages of 5 and 18 living at home. Similarly situated families who had not been reported for neglect or abuse were selected from those same counties for a matched control group. Data collection efforts involved: caseworker interviews, home administered questionnaires, home interviews of 103 neglect and 102 control families, in-home videotaped interactions of 92 neglect and 95 control families, and follow-up interviews in some cases.

Investigators: Gaudin, J. M. & Polansky, N.A.
Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry

Background
          Neurons in the dorsal spinal cord play important roles in nociception and pain. These neurons receive input from peripheral sensory neurons and then transmit the signals to the brain, as well as receive and integrate descending control signals from the brain. Many molecules important for pain transmission have been demonstrated to be localized to the dorsal horn of the spinal cord. Further understanding of the molecular interactions and signaling pathways in the dorsal horn neurons will require a better knowledge of the molecular neuroanatomy in the dorsal spinal cord.
        
        
          Results
          A large scale screening was conducted for genes with enriched expression in the dorsal spinal cord using DNA microarray and quantitative real-time PCR. In addition to genes known to be specifically expressed in the dorsal spinal cord, other neuropeptides, receptors, ion channels, and signaling molecules were also found enriched in the dorsal spinal cord. In situ hybridization and immunohistochemistry revealed the cellular expression of a subset of these genes. The regulation of a subset of the genes was also studied in the spinal nerve ligation (SNL) neuropathic pain model. In general, we found that the genes that are enriched in the dorsal spinal cord were not among those found to be up-regulated in the spinal nerve ligation model of neuropathic pain. This study also provides a level of validation of the use of DNA microarrays in conjunction with our novel analysis algorithm (SAFER) for the identification of differences in gene expression.
        
        
          Conclusion
          This study identified molecules that are enriched in the dorsal horn of the spinal cord and provided a molecular neuroanatomy in the spinal cord, which will aid in the understanding of the molecular mechanisms important in nociception and pain.
2012 Uniform Reporting System (URS) Tables for Guam

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Prednisone

Prednisone is a prescription corticosteroid that helps reduce inflammation and suppress the immune system. It's commonly used to treat conditions like allergies, arthritis, asthma, and certain autoimmune disorders. Available as oral tablets in strengths of 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg, manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Compound 528792: Cyclotetracosasiloxane, octatetracontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46,48,48-octatetracontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47-tetracosaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46,48-tetracosasilacyclooctatetracontane. Molecular Formula: C48H144O24Si24. Molecular Weight: 1779.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AHRQ Pediatric Quality Indicators for California Hospitals

The Pediatric Quality Indicators (PDIs), developed by the federal Agency for Healthcare Research and Quality (AHRQ), identify potential quality and patient safety issues specific to the pediatric inpatient population. HCAI will report hospital-level results on five PDIs - Accidental Puncture or Laceration, Neonatal Blood Stream Infection, Postoperative Respiratory Failure, Postoperative Sepsis, and Central Venous Catheter-Related Blood Stream Infection. The results were generated with the AHRQ software  version 2023. This dataset does not include complications acquired in outpatient settings.
MONAHRQ

<p>MONAHRQ® is a desktop software tool that enables organizations—such as state and local data organizations, regional reporting collaborations, hospitals and hospital systems, nursing homes and nursing home organizations, and health plans—to quickly and easily generate a health care reporting website.</p>
<p>Effective September 27, 2017, technical support and software updates will no longer be available. Version 7, build 5, will be the final update. Existing software and supporting materials will remain available on this site. In addition, the open source project will remain active with software and materials available through GitHub: <a href="https://github.com/AHRQ/MONAHRQ-Open-Source">https://github.com/AHRQ/MONAHRQ-Open-Source</a></p>
Citrullination: a small change for a protein with great consequences for rheumatoid arthritis

A new autoantibody activity, which is almost 100% specific for rheumatoid arthritis (RA), has been found. The essential part of the B-cell epitope is a modified form of arginine (ie citrulline). The conversion of protein-contained arginine to citrulline is an enzymatic process that is carried out by peptidylarginine deiminase (PAD), an enzyme that appears to be hormonally controlled. Because of its remarkable specificity, citrullination and related processes might open new possibilities for studying the aetiology of RA.
Compound 527065: 9,13,17-Trimethylhentriacontane

Chemical compound data from PubChem database. IUPAC Name: 9,13,17-trimethylhentriacontane. Molecular Formula: C34H70. Molecular Weight: 478.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.